Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
Clinical trial NCT04462198 · COMPLETED
Trial details
- NCT number
- NCT04462198
- Sponsor
- Contineum Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2021-06-17
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.